A Vanderbilt researcher has been awarded $6.2 million to study the effect of opioids on the brain.

With opioid prescriptions plummeting and no more pharma companies to sue, America's drug warriors are running out of bogeymen ...

A good night's sleep often sets the stage for a positive day. But for the nearly quarter of American adults struggling with ...

It works by switching off nociceptors in the peripheral nervous system, and therefore preventing pain signals getting to the brain. This represents a potential new breakthrough in a world which has ...

The cerebral cortex is the largest part of a mammal's brain, and by some measures, the most important. In humans in particular, it's where most things happen—like perception, thinking, memory storage ...

Meet suzetrigine, a non-opioid that promises to avoid addiction risk. But some experts say it can't replace opioids ...

After reading a recent Sun-Times investigation on opioid deaths among a generation of Black men, WBEZ editor Alden Loury ponders the role of racism and segregation in those deaths.

We are collecting data on people who have sought ibogaine treatment all around the world so we can start to collect a very ...

The FDA has approved Journavx, a new non-opioid painkiller designed to treat moderate to severe acute pain. Unlike opioids, ...

For the first time in 20 years, the Food and Drug Administration has approved a new pharmaceutical approach to treating pain.

Researchers have identified how CBD interacts with cannabinoid receptors to mitigate the negative effects of THC, the psychoactive component of cannabis.